項目 | 內容 |
---|---|
時間 | 2023-02-18的09:00至12:35 |
類型 | 丙類 |
積分 | 1 |
主辦單位 | 台灣武田藥品工業股份有限公司 |
會議地點 | 張榮發基金會10F (1002會議室) |
武田亞太區血液腫瘤高峰會-淋巴瘤
Takeda Asia-Pacific Onco Summit – Lymphoma
參加會議報名連結(Registration Link)
T-cell Lymphoma 1. The international consensus of T cell lymphoma classification 2. Optimal treatment strategies for PTCL 3. Clinical trial landscape in PTCL B-cell Lymphoma 4. An Italian perspective on Newly Diagnosed HL management - prime time for novel agents? 5. Dilemma in R/R DLBCL - what, when, how?
T-cell Lymphoma 1. The international consensus of T cell lymphoma classification 2. Optimal treatment strategies for PTCL 3. Clinical trial landscape in PTCL B-cell Lymphoma 4. An Italian perspective on Newly Diagnosed HL management - prime time for novel agents? 5. Dilemma in R/R DLBCL - what, when, how?
檔案下載